ClassID:

21578

A61K51/087 - CPC Classification

Classification description:

Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being an annexin, e.g. annexin V

Recent Application in this class:
#1
20220031872
2022-02-03

Lyophilized Compositions Comprising Rhannexin V-128, Process for Their Preparation and Their Use for Preparing Formulations Containing 99MTc-Rhannexin V-128

#2
20200038526
2020-02-06

Lyophilized Compositions Comprising Rhannexin V-128, Process for Their Preparation and Their Use for Preparing Formulations Containing 99MTc-Rhannexin V-128

#3
20200031911
2020-01-30

Anti human annexin A1 antibody

#4
20170128570
2017-05-11

Annexin II compositions

#5
20160114062
2016-04-28

TREATMENT OF IMMUNE, INFLAMMATORY AND DEGENERATIVE ARTHRITIDES WITH TIN-117m

#6
20160101198
2016-04-14

Method of diagnosing and treating Alzheimer's disease

#7
20140212356
2014-07-31

Methods and compositions for treating luminal inflammatory disease

#8
20140127736
2014-05-08

Annexin V variant and its preparation and application

#9
20140127130
2014-05-08

Radiofluorinated compounds and their preparation

#10
20130331546
2013-12-12

Annexin II compositions

#11
20130259802
2013-10-03

Radiofluorinated compounds and their preparation

#12
20130149239
2013-06-13

5-PYRROLIDINYLSULFONYL-ISATIN DERIVATIVES

#13
20120171117
2012-07-05

Radiofluorinated compounds and their preparation

#14
20110269943
2011-11-03

RADIOLABELED ANNEXINS

#15
20110251486
2011-10-13

Radiolabeled annexins

#16
20110097267
2011-04-28

COMPOSITIONS FOR IMAGING PAIN AND STRESS IN VIVO

#17
20110077211
2011-03-31

Methods and compositions for treating luminal inflammatory disease

#18
20100284922
2010-11-11

Composition comprising a cell death marker and a wavelength-optimized label

#19
20100204457
2010-08-12

Preparation of annexin derivatives

#20
20100055035
2010-03-04

Bisaminoethanethiol-targeting ligand conjugates and compositions

#21
20090087379
2009-04-02

Radiofluorinated compounds and their preparation

#22
20090041664
2009-02-12

5-pyrrolidinylsulfonyl isatin derivatives

#23
20080227961
2008-09-18

Bridged aromatic substituted amine ligands with donor atoms

#24
20080138279
2008-06-12

Method of imaging cell death in vivo

#25
20070297976
2007-12-27

Metal ion-labeled bis-aminoethanethiol-targeting ligand conjugates, compositions, and methods for tissue-specific disease imaging

#26
20070243133
2007-10-18

Method of imaging cell death in vivo

#27
20070196275
2007-08-23

Diagnostic Imaging Compositions, Their Methods Of Synthesis And Use

#28
20070148092
2007-06-28

Compositions and methods for imaging pain and stress in vivo

#29
20070122342
2007-05-31

Ethylenedicysteine (EC)-drug conjugates compositions and methods for tissue specific disease imaging

#30
20070031333
2007-02-08

Novel F-18 labeled annexin V, synthesis thereof, and use thereof

#31
20070021641
2007-01-25

Methods and compositions for treating luminal inflammatory disease

#32
20060188438
2006-08-24

Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging

#33
20060029545
2006-02-09

Radiolabeled annexins

#34
20050276754
2005-12-15

Bridged aromatic substituted amine ligands with donor atoms

#35
20050095198
2005-05-05

Annexin derivatives with endogenous chelation sites

#36
20050084448
2005-04-21

Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging

#37
20050079133
2005-04-14

Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging

#38
20050036948
2005-02-17

Radiolabeled annexins

#39
20050013778
2005-01-20

Methods and compositions for predicting the response to a therapeutic regimen in a subject having a disease associated with cell death